Medical cannabis in the UK and the industry’s future
Despite the evidence of the growing potential of the cannabis industry and wider acceptance, the domestic distribution of medical cannabis remains low.
Medical cannabis: The next innovation in oncology?
The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp of a breakthrough in oncology.
Could North Carolina get a medical marijuana law? Bill passes another committee vote
A bill that could legalize medical marijuana in North Carolina is taking a long, winding road through the state Senate, but the bill’s Republican sponsors have managed to get it successfully through several committees.
Cherokee legalizes medical marijuana
The Cherokee Tribal Council today approved a 42-page ordinance that will establish a system to support legalized medical marijuana on the Qualla Boundary.
Texas cancer patients and people with PTSD will soon be able to join state’s expanded medical marijuana program
David Bass, a military veteran diagnosed with post-traumatic stress disorder, at his home in Killeen on Sunday. He’s used illegal marijuana to treat symptoms, but plans to enroll in the state’s medical cannabis program that expands Sept. 1.
First-Ever Human Trial To Test Medical Cannabis As Brain Cancer Therapy
A cannabis-based mouth spray is set to be tested as a potential treatment for an aggressive form of brain tumor called glioblastoma, marking the first-ever major human trial involving medical cannabis as a cancer therapy.
Cannabinoids in dermatology: a scoping review
The therapeutic applications of cannabis and cannabinoids are an increasingly conspicuous topic as de-criminalization and legalization of these products continues to expand. We conducted a review of the current literature to determine the applications of cannabinoids for the therapy of various skin diseases. After conducting our analysis, we found that cannabinoid products have the potential to treat a variety of skin conditions, including acne vulgaris, allergic contact dermatitis, asteatotic dermatitis, atopic dermatitis, hidradenitis suppurativa, Kaposi sarcoma, pruritus, psoriasis, skin cancer, and the cutaneous manifestations of systemic sclerosis.
Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice
Several recent findings suggest that targeting the endogenous cannabinoid system can be considered as a potential therapeutic approach to treat Alzheimer’s disease (AD). The present study supports this hypothesis demonstrating that delta-9-tetrahydrocannabinol (THC) or cannabidiol (CBD) botanical extracts, as well as the combination of both natural cannabinoids, which are the components of an already approved cannabis-based medicine, preserved memory in AβPP/PS1 transgenic mice when chronically administered during the early symptomatic stage.